FindTrial
Sign In

To check sensitivity of antibiotic towards bacteria causing urinary tract infection

Fosfomycin susceptibility among clinical isolates of carbapenem resistant enterobacteriaceae.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015475
Enrollment
140
Registered
2018-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

Institutional seeded money
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-duplicate strains of carbapenemase resistant enterobacteriaceae species isolated from patients admitted at Kasturba Medical College Hospital, Manipal.

Exclusion criteria

Exclusion criteria: 1. Non carbapenem resistant enterobacteriaceae. 2. Non enterobacteriaceae isolates.

Design outcomes

Primary

MeasureTime frame
Antimicrobial susceptibility of clinical isolates of MDR enterobacteriaceae. Timepoint: 15 september 2018 to 15 december 2018—

Secondary

MeasureTime frame
Antimicrobial susceptibility of MDR enterobacteriaceae towards Fosfomycin.Timepoint: 15 september 2018 to 15 december 2018—

Countries

India

Contacts

Public ContactDr Saleena Ummer Velladath

School Of Allied Health Sciences, Manipal Academy of Higher Education, Manipal

saleena.ummer@manipal.edu9880546035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026